April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

2 mEq/mL, 20 mEq/10 mL vials, package of 25 (NDC 00409-6651-06) 40 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00409-7109-09) 20 mEq/1000 mL in 0.45% sodium chloride (NDC 00409-9257-39) Reason for the Shortage • APP states the reason for the shortage is increased demand. • Hospira states the reason for the shortage is manufacturing delays. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=696 Source: www.ashp.org Mannitol Injection March 21, 2012 Products Affected - Description Mannitol injection, American Regent 250 mg/mL, 50 mL vial, 25 count (NDC 00517-4050-25) Mannitol injection, APP 250 mg/mL, 50 mL vial, 25 count (NDC 63323-0024-25) Mannitol injection, Hospira 250 mg/mL, 50 mL vial, 25 count (NDC 00409-4031-01) 200 mg/mL, 250 mL premixed bag (NDC 00409-7715-02) 200 mg/mL, 500 mL premixed bag (NDC 00409-7715-03) Reason for the Shortage • Hospira has mannitol injection on shortage due to manufacturing delays. • APP has mannitol injection on shortage due to increased demand for the product. • BBraun had mannitol injection on shortage due to increased demand for the product. • American Regent had temporarily suspended manufacture of most drug products in April, 2011. • American Regent resumed manufacturing in Shirley, New York in early-May, 2011. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=863 Source: www.ashp.org Vitamin A Injection March 22, 2012 Products Affected - Description Aquasol A, Hospira 50,000 units/mL, 1 mL ampule (NDC 61703-0418-07) Reason for the Shortage • Hospira is changing manufacturing sites from a 3rd party manufacturer to in-house manufacturing. This has caused a delay in production. • Hospira is the sole manufacturer of vitamin A injection. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=704 Source: www.ashp.org Orphenadrine Citrate Injection March 22, 2012 Products Affected - Description Orphenadrine citrate injection, 30 mg/mL, Bedford 2 mL vial, 10 count (NDC 55390-0059-10) Reason for the Shortage • Watson stated the shortage was due to production delays. 56
• Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011. Product will become available in stages as production resumes. • Bedford Laboratories has multiple products affected by this suspension of manufacturing. Availability of all products, including those not manufactured at Ben Venue, is updated as information changes on the Bedford Laboratories website. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=884 Source: www.ashp.org Labetalol Tablets March 22, 2012 Products Affected - Description Labetalol tablets, Sandoz 100 mg, 100 count (NDC 00185-0010-01) 200 mg, 500 count (NDC 00185-0117-05) Labetalol tablets, Teva 100 mg, 500 count (NDC 00172-4364-70) 200 mg, 100 count, unit dose (NDC 00172-4365-10) 200 mg, 500 count (NDC 00172-4365-70) Labetalol tablets, Watson 100 mg, 100 count (NDC 00591-0605-01) 100 mg, 500 count (NDC 00591-0605-05) 200 mg, 100 count (NDC 00591-0606-01) 200 mg, 500 count (NDC 00591-0606-05) 300 mg, 100 count (NDC 00591-0607-01) Trandate tablets, Prometheus 100 mg, 100 count (NDC 65483-0391-10) 200 mg, 100 count (NDC 65483-0392-10) 300 mg, 100 count (NDC 65483-0393-10) Reason for the Shortage • Major, Sandoz, Teva, Prometheus cannot provide a reason for the shortage. • Watson has labetalol tablets on back order due to increased demand. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=840 Source: www.ashp.org Aminophylline Injection March 22, 2012 Products Affected - Description Aminophylline injection, American Regent 25 mg/mL, 10 mL vial (NDC 00517-3810-25) 25 mg/mL, 20 mL vial (NDC 00517-3820-25) Aminophylline injection, Hospira 25 mg/mL, 20 mL ampule (NDC 00409-7386-01) - discontinued Reason for the Shortage • American Regent had temporarily suspended distribution of most drug products in April, 2011. • American Regent resumed manufacturing in Shirley, New York in early-May, 2011. • Hospira states that the shortage was due to manufacturing delays. • Hospira discontinued aminophylline ampules in September, 2011. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=705 57
Page 1 and 2:
April 2012 Drug Information Update
Page 3 and 4:
First-Time Generics GENERIC DRUG NA
Page 5 and 6: GENERAL ANESTHETICS, INJECTABLE MID
Page 7 and 8: Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10: Statin Drugs - Drug Safety Communic
Page 11 and 12: Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14: low blood sugar (hypoglycemia) in p
Page 15 and 16: Some women with depression who beco
Page 17 and 18: Survival increased for all groups o
Page 19 and 20: finding that it also may reduce the
Page 21 and 22: Syringes (2 mL size), Rx only. NDC
Page 23 and 24: Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37 and 38: Reason for the Shortage • Ben Ven
Page 39 and 40: Products Affected - Description Gan
Page 41 and 42: 37.5 mg/25 mg, 1000 count (NDC 0078
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45 and 46: 500 mg, 100 count (NDC 63304-0726-0
Page 47 and 48: 750 mg tablets, 100 count (NDC 1013
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54: Ciprofloxacin Immediate-Release Tab
Page 55: • APP had tobramycin 40 mg/mL pre
Page 59 and 60: 50 mg/mL, 10 mL vial, package of 10
Page 61 and 62: 2 mL vial, preservative-free (NDC 6
Page 63 and 64: 5 mg single dose vial, package of 1
Page 65 and 66: 20 mL glass ampule, sterile pack (N
Page 67 and 68: 2 mL iSecure syringe (NDC 00406-112
Page 69 and 70: Lidocaine 0.5% Xylocaine 0.5% injec
Page 71 and 72: • Teva discontinued all ciproflox
Page 73 and 74: Nicardipine hydrochloride injection
Page 75 and 76: Article link: http://www.ashp.org/D
Page 77 and 78: • Apotex had metformin products u
Page 79: • Covis purchased all rights to F
show all

April 2012 Drug Information Update - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?